"Corrigendum: β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-Pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial–Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Corrigendum: β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-Pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial–Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling

[This corrects the article DOI: 10.3389/fphar.2018.01525.]. Click to show full abstract

[This corrects the article DOI: 10.3389/fphar.2018.01525.].

Keywords: corrigendum sitosterol; gemcitabine exhibit; synergistic anti; sitosterol gemcitabine; exhibit synergistic; anti pancreatic

Journal Title: Frontiers in Pharmacology
Year Published: 2020

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
0

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended